Taro Pharmaceutical EPS misses by $0.11, beats on revenue

May 19, 2021 5:44 PM ETTaro Pharmaceutical Industries Ltd. (TARO)By: Pranav Ghumatkar, SA News Editor
  • Taro Pharmaceutical (NYSE:TARO): Q1 Non-GAAP EPS of $0.81 misses by $0.11; GAAP EPS of -$0.78 misses by $1.70.
  • Revenue of $148.35M (-15.2% Y/Y) beats by $1.02M.
  • Press Release

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.